Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Dec 13, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 13, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 7, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 9, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Nov 5, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Nov 5, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 4, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 2, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 27, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 25, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 5, 2010View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Sep 24, 2010View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-84

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information